Status:
COMPLETED
Insulin Treatment in Cancer Cachexia
Lead Sponsor:
Göteborg University
Collaborating Sponsors:
Swedish Cancer Foundation
Medical Research Council
Conditions:
Cancer Cachexia
Eligibility:
All Genders
25-85 years
Phase:
PHASE4
Brief Summary
The study is designed to evaluate whether daily insulin treatment to weight losing cancer patients attenuates progression of cancer cachexia and improves metabolism.
Detailed Description
Randomized study with long-term follow-up based on survival, health related quality of life, food intake, resting energy expenditure, body composition, exercise capacity and measurement of metabolic e...
Eligibility Criteria
Inclusion
- Weight loss
- Systemic solid cancer
Exclusion
- Diabetes
- Brain metastases
- Expectant survival of less than 6 months
- Serum creatinine above 200 umol/l
- Persistent of recurrent fever
- Cholestasis
Key Trial Info
Start Date :
January 1 2000
Trial Type :
INTERVENTIONAL
End Date :
September 1 2005
Estimated Enrollment :
135 Patients enrolled
Trial Details
Trial ID
NCT00329615
Start Date
January 1 2000
End Date
September 1 2005
Last Update
August 21 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Surgery, Inst of Clinical Sciences
Gothenburg, Sweden, SE413 45